China Resources Double-Crane Pharmaceutical Co.,Ltd.

SSE:600062.SS

19.27 (CNY) • At close June 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994
Revenue 11,211.62410,222.1329,446.9259,111.5178,503.9389,380.998,225.0836,421.8475,494.8045,138.3954,280.9616,834.5746,989.3236,383.3755,366.7965,037.9464,951.5244,556.6164,049.094,597.4294,195.7154,249.2113,686.3212,382.6571,168.339723.168350.666236.309208.445168.111156.724
Cost of Revenue 4,790.8584,606.9084,231.8154,029.9733,145.1923,430.6433,014.4262,733.7422,576.4952,473.1232,205.9824,469.9574,661.454,321.4683,424.9363,327.5963,417.7253,186.2542,902.7763,365.1583,085.9113,096.8122,544.8211,500.426633.986447.539227.24160.905131.108103.368107.002
Gross Profit 6,420.7665,615.2245,215.115,081.5445,358.7475,950.3475,210.6573,688.1052,918.3092,665.2732,074.9792,364.6172,327.8732,061.9081,941.861,710.351,533.7991,370.3621,146.3141,232.2711,109.8041,152.41,141.5882.23534.353275.629123.42675.40477.33764.74349.721
Gross Profit Ratio 0.5730.5490.5520.5580.630.6340.6340.5740.5310.5190.4850.3460.3330.3230.3620.3390.310.3010.2830.2680.2650.2710.310.370.4570.3810.3520.3190.3710.3850.317
Reseach & Development Expenses 555.191561.459474.719409.593291.018202.007144.741152.196120.555143.80288.64358.6745.76154.85250.1890000000000000000
General & Administrative Expenses 201.62162.499131.065148.787118.406123.654125.929114.803118.423119.32997.637157.606124.011112.4890.664292.322290.884224.677361.685349.332435.431395.239366.668262.548142.62293.26836.0117.35711.2696.4454.763
Selling & Marketing Expenses 2,281.581,882.9852,656.0452,807.3143,029.4183,730.2563,193.7541,877.8371,317.7161,225.622932.3631,043.5941,122.4041,004.524974.004836.872748.563660.694534.241642.83537.723554.941541.715403.82202.08573.62816.6069.22211.379.028.714
SG&A 2,483.23,246.3622,787.1092,956.1023,147.8243,853.9113,319.6831,992.641,436.1391,344.9511,0301,201.21,246.4151,117.0041,064.6681,129.1931,039.447885.371895.926992.162973.153950.18908.383666.368344.707166.89652.61726.57922.63915.46513.477
Other Expenses 1,547.938292.368639.714612.801682.936589.259-5.203-6.43969.31249.46827.45333.34933.04662.52531.39922.88118.624180.91948.607-16.16812.10820.32321.11219.84211.33516.47612.5864.416-00.0030.627
Operating Expenses 4,586.3294,100.1883,901.5423,978.4954,121.7784,645.1764,031.312,612.3432,060.8011,918.6371,453.0511,561.7751,613.521,412.5031,335.3011,163.8631,071.914913.466920.3691,017.178996.669972.271932.626684.292355.92173.85354.60827.57223.71416.74514.104
Operating Income 1,834.4371,515.0361,406.1311,136.951,229.2641,262.4861,189.3121,060.358843.205764.33638.4011,033.89731.272655.224592.688542.201452.031393.765222.099270.03529.886116.713208.248188.977175.09593.22273.51148.85750.66344.15531.676
Operating Income Ratio 0.1640.1480.1490.1250.1450.1350.1450.1650.1530.1490.1490.1510.1050.1030.110.1080.0910.0860.0550.0590.0070.0270.0560.0790.150.1290.210.2070.2430.2630.202
Total Other Income Expenses Net 32.24651.4877.865-15.76-14.247-0.689-5.203-6.43959.47142.43241.63832.88831.48647.76822.27417.92418.624180.91921.188-29.358-85.053-10.63-2.6554.385-22.86311.3911.2134.237-00.0030
Income Before Tax 1,866.6831,566.5231,414.6071,121.191,215.0181,261.7971,184.1091,053.918906.794806.762658.3781,066.778762.758702.992616.902561.443470.655574.684253.058240.67627.969106.238205.594193.362179.433104.61384.72453.09350.66344.15731.676
Income Before Tax Ratio 0.1660.1530.150.1230.1430.1350.1440.1640.1650.1570.1540.1560.1090.110.1150.1110.0950.1260.0620.0520.0070.0250.0560.0810.1540.1450.2420.2250.2430.2630.202
Income Tax Expense 215.942240.615199.256149.058201.522195.341194.657171.818167.546141.941114.713193.334132.211150.47483.90797.99174.199117.07767.53951.85553.35254.68459.44231.31540.8329.36123.5985.544-2.960.1690.215
Net Income 1,627.7181,333.0291,180.062935.6851,005.1621,055.124968.593842.612714.211661.064541.908870.69614.408528.999520.095451.457380.572437.581164.893186.6394.70564.631168.442157.71128.91575.88560.87847.54950.66343.98831.462
Net Income Ratio 0.1450.130.1250.1030.1180.1120.1180.1310.130.1290.1270.1270.0880.0830.0970.090.0770.0960.0410.0410.0010.0150.0460.0660.110.1050.1740.2010.2430.2620.201
EPS 1.581.631.140.90.961.010.930.810.680.630.711.060.750.640.630.550.470.570.220.240.0060.0830.220.20.160.110.0950.0740.0670.0580.041
EPS Diluted 1.581.631.140.90.961.010.930.810.680.630.711.060.750.640.630.550.470.570.220.240.0060.0830.220.20.160.110.0950.0740.0670.0580.041
EBITDA 2,635.2472,224.8441,996.4341,588.6591,596.9711,632.8491,541.0021,393.4491,227.6131,089.6871,087.8271,364.831983.652902.963787.333695.929610.366562.61370.165408.308198.392255.283332.483292.078213.347164.36581.47847.83253.62347.998-14.104
EBITDA Ratio 0.2350.2180.2110.1740.1880.1740.1870.2170.2230.2120.2540.20.1410.1410.1470.1380.1230.1230.0910.0890.0470.060.090.1230.1830.2270.2320.2020.2570.286-0.09